U.S. stock indexes closed lower on Tuesday, with the Dow Jones Industrial Average dropping 0.8% to 49,191.99. The S&P 500 slipped nearly 0.2% to 6,963.74, while the Nasdaq edged down 0.1% to 23,709.87.
But beneath the surface, certain stocks made big moves that had retail traders and institutional investors talking. Here's what caught everyone's attention.
Intel Rides the AI Wave
Intel Corporation (INTC) saw a notable rise of 7.33%, closing at $47.29. The stock reached an intraday high of $48.24 and a low of $45.22, with its 52-week range between $48.24 and $17.67.
The surge came after KeyBanc upgraded the chipmaker on the back of strong AI server demand. Analyst John Vinh pointed to weakness in traditional servers but highlighted the growing opportunity in AI infrastructure as a key driver for the upgrade. It's the kind of narrative investors love right now: legacy tech company pivots to AI and suddenly looks relevant again.
Moderna Gets a Boost from Updated Guidance
Moderna Inc. (MRNA) experienced a significant increase of 17.02%, closing at $39.60. The stock's intraday high was $39.71, with a low of $34.05, and its 52-week high and low are $45.40 and $22.29, respectively.
Shares of Moderna jumped sharply after the company updated investors on its outlook and pipeline at the J.P. Morgan Healthcare Conference. The biotech firm now expects 2025 revenue of about $1.9 billion, which is $100 million above the prior midpoint. Even better, the company is cutting projected GAAP operating expenses by $200 million and lifting its expected year-end cash balance to roughly $8.1 billion.
That's the trifecta investors want to hear: higher revenue, lower costs, and more cash on the balance sheet.




